RAD51C Gene Breast-Ovarian Cancer NGS Genetic DNA Test

Comprehensive Genetic Testing for Hereditary Cancer Risk

The RAD51C Gene Breast-Ovarian Cancer NGS Genetic DNA Test represents a breakthrough in personalized cancer risk assessment. This advanced genetic screening utilizes Next-Generation Sequencing (NGS) technology to detect mutations in the RAD51C gene, which plays a critical role in DNA repair mechanisms. When this gene contains harmful mutations, it significantly increases an individual’s susceptibility to developing hereditary breast and ovarian cancers.

Understanding your genetic predisposition to cancer is essential for proactive health management. The RAD51C gene belongs to the family of DNA repair genes, and mutations in this gene can disrupt the body’s natural ability to repair DNA damage, leading to uncontrolled cell growth and cancer development. Early identification of these genetic markers allows for timely intervention and personalized prevention strategies.

What the RAD51C Test Measures and Detects

This comprehensive genetic test specifically analyzes the RAD51C gene for:

• Pathogenic mutations that significantly increase cancer risk
• Variants of uncertain significance that may require further investigation
• Specific genetic alterations associated with hereditary breast and ovarian cancer syndromes
• DNA sequence variations that impact protein function and DNA repair capabilities

The test employs state-of-the-art NGS technology, which provides high-resolution analysis of the entire RAD51C gene sequence. This advanced methodology ensures comprehensive coverage and accurate detection of even rare genetic variants that might be missed by conventional testing methods.

Who Should Consider RAD51C Genetic Testing?

Individuals with the following characteristics are ideal candidates:

• Personal history of breast cancer diagnosed before age 50
• Family history of multiple cases of breast or ovarian cancer
• Ashkenazi Jewish ancestry with family cancer history
• Personal or family history of bilateral breast cancer
• Male breast cancer in the family
• Multiple primary cancers in the same individual
• Family members with known RAD51C mutations
• Unexplained family clusters of pancreatic or prostate cancer

Clinical Symptoms and Indicators:

• Early-onset breast cancer (before age 45)
• Triple-negative breast cancer diagnosis
• Ovarian cancer at any age
• Multiple generations affected by related cancers
• Cancer diagnoses in multiple close relatives

Benefits of RAD51C Genetic Testing

Undergoing RAD51C genetic testing provides numerous advantages for cancer prevention and management:

Personalized Risk Assessment

Receive detailed information about your specific cancer risk profile, enabling tailored screening and prevention strategies based on your genetic makeup.

Early Detection Opportunities

Identify high-risk individuals before cancer develops, allowing for enhanced surveillance and early intervention when treatment is most effective.

Family Planning Guidance

Understand inheritance patterns and provide valuable information for family members who may also be at risk, enabling proactive health decisions across generations.

Treatment Personalization

For those already diagnosed with cancer, genetic test results can inform treatment decisions and help identify targeted therapies that may be more effective.

Peace of Mind

Reduce uncertainty about cancer risk and make informed decisions about your health management with confidence.

Understanding Your Test Results

Positive Result (Mutation Detected)

A positive result indicates the presence of a harmful RAD51C gene mutation. This does not mean you will definitely develop cancer, but rather that your risk is significantly elevated. Our genetic counselors will provide comprehensive guidance on:

• Enhanced cancer screening recommendations
• Risk-reduction strategies
• Preventive medication options
• Surgical prevention considerations
• Family testing recommendations

Negative Result (No Mutation Detected)

A negative result means no harmful RAD51C mutations were identified. However, it’s important to understand that this doesn’t eliminate all cancer risk. Your overall cancer risk should still be assessed based on personal and family history factors.

Variant of Uncertain Significance (VUS)

Sometimes, the test identifies genetic changes whose clinical significance is unknown. In these cases, ongoing research may provide additional information over time, and our team will monitor scientific developments related to your specific variant.

Test Pricing and Availability

Test Details:

• Turnaround Time: 3 to 4 Weeks
• Sample Type: Blood, Extracted DNA, or One Drop Blood on FTA Card
• Pre-test Requirements: Clinical History and Genetic Counseling Session
• Specialty: Oncology Genetics
• Methodology: Next-Generation Sequencing (NGS) Technology

Nationwide Availability and Booking

We have branches conveniently located across the United States, serving major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network of certified genetic counselors and medical professionals ensures you receive comprehensive support throughout the testing process.

Take the first step toward understanding your genetic cancer risk. Our team is ready to provide the guidance and support you need for informed health decisions.

Ready to Schedule Your Test?

Contact us today to book your RAD51C Gene Breast-Ovarian Cancer NGS Genetic DNA Test. Our genetic counseling team will help you understand the testing process, discuss your family history, and ensure you’re fully prepared for your genetic assessment.

Call or WhatsApp: +1(267) 388-9828

Don’t wait to take control of your health future. Early detection and proactive management can make a significant difference in cancer prevention and outcomes. Schedule your appointment today and join thousands of Americans who have gained valuable insights into their genetic health through our comprehensive testing services.